- Home
- PIII vs RANI Comparison
PIII vs RANI Comparison
Compare PIII & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PIII
- RANI
- Stock Information
- Founded
- PIII 2015
- RANI 2012
- Country
- PIII United States
- RANI United States
- Employees
- PIII N/A
- RANI N/A
- Industry
- PIII Medical/Nursing Services
- RANI Medicinal Chemicals and Botanical Products
- Sector
- PIII Health Care
- RANI Health Care
- Exchange
- PIII Nasdaq
- RANI Nasdaq
- Market Cap
- PIII 28.6M
- RANI 23.2M
- IPO Year
- PIII N/A
- RANI 2021
- Fundamental
- Price
- PIII $8.38
- RANI $0.50
- Analyst Decision
- PIII Strong Buy
- RANI Strong Buy
- Analyst Count
- PIII 3
- RANI 4
- Target Price
- PIII $17.50
- RANI $7.75
- AVG Volume (30 Days)
- PIII 7.0K
- RANI 429.7K
- Earning Date
- PIII 11-11-2025
- RANI 11-13-2025
- Dividend Yield
- PIII N/A
- RANI N/A
- EPS Growth
- PIII N/A
- RANI N/A
- EPS
- PIII N/A
- RANI N/A
- Revenue
- PIII $1,461,823,000.00
- RANI $1,200,000.00
- Revenue This Year
- PIII N/A
- RANI N/A
- Revenue Next Year
- PIII $9.46
- RANI N/A
- P/E Ratio
- PIII N/A
- RANI N/A
- Revenue Growth
- PIII 4.20
- RANI N/A
- 52 Week Low
- PIII $5.80
- RANI $0.39
- 52 Week High
- PIII $26.99
- RANI $3.75
- Technical
- Relative Strength Index (RSI)
- PIII 59.01
- RANI 46.37
- Support Level
- PIII $8.46
- RANI $0.47
- Resistance Level
- PIII $8.90
- RANI $0.51
- Average True Range (ATR)
- PIII 0.32
- RANI 0.04
- MACD
- PIII -0.02
- RANI -0.00
- Stochastic Oscillator
- PIII 49.07
- RANI 34.71
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.